Ingevity Corp (NGVT) - Total Liabilities
Based on the latest financial reports, Ingevity Corp (NGVT) has total liabilities worth $1.61 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Ingevity Corp (NGVT) net asset momentum to track the company's year-over-year net asset growth rate.
Ingevity Corp - Total Liabilities Trend (2013–2025)
This chart illustrates how Ingevity Corp's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Ingevity Corp to measure how efficiently the company converts operating cash flow to free cash.
Ingevity Corp Competitors by Total Liabilities
The table below lists competitors of Ingevity Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Paz Oil
TA:PZOL
|
Israel | ILA7.69 Billion |
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
China | CN¥3.09 Billion |
|
Sopra Steria Group SA
PA:SOP
|
France | €3.59 Billion |
|
Sinomag Technology Co Ltd
SHE:300835
|
China | CN¥1.19 Billion |
|
Genting Malaysia Bhd
KLSE:4715
|
Malaysia | RM19.44 Billion |
|
Avepoint Inc
NASDAQ:AVPT
|
USA | $295.38 Million |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩174.97 Billion |
|
BGI Genomics Co Ltd
SHE:300676
|
China | CN¥2.81 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Ingevity Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Ingevity Corp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 41.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.98 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ingevity Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ingevity Corp (2013–2025)
The table below shows the annual total liabilities of Ingevity Corp from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.62 Billion | -11.27% |
| 2024-12-31 | $1.83 Billion | -8.26% |
| 2023-12-31 | $1.99 Billion | -2.27% |
| 2022-12-31 | $2.04 Billion | +13.54% |
| 2021-12-31 | $1.80 Billion | +6.40% |
| 2020-12-31 | $1.69 Billion | +4.56% |
| 2019-12-31 | $1.61 Billion | +65.40% |
| 2018-12-31 | $975.60 Million | +49.49% |
| 2017-12-31 | $652.60 Million | -6.53% |
| 2016-12-31 | $698.20 Million | +168.54% |
| 2015-12-31 | $260.00 Million | -12.75% |
| 2014-12-31 | $298.00 Million | +12.45% |
| 2013-12-31 | $265.00 Million | -- |
About Ingevity Corp
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sell… Read more